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which comprise only a small percentage of all cells in the adventitia,
in calcifying medium resulted in calciﬁcation.
RESULTS Following 48 weeks, calciﬁed lesions were observed in the
aorta adventitia and coronary artery adventitia of ApoE-/-mice. Von
Kossa staining showed calciﬁcation in the human aorta adventitia.
Explant culture of ﬁbroblasts, was successfully induced for calciﬁca-
tion after incubation with TGF-b1 (20 ng/ml) þ mineralization media
for 4 days, and the phenotype conversion of vascular adventitial ﬁ-
broblasts into myoﬁbroblasts was identiﬁed. Culture of smooth mus-
cle cells (SMCs), which comprise only a small percentage of all cells in
the adventitia, in calcifying medium for 14 days resulted in signiﬁcant
calciﬁcation.
CONCLUSIONS Vascular calciﬁcation can occur in the adventitia.
The conversion of ﬁbroblasts into myoﬁbroblasts may contribute
to the calciﬁcation process. Although SMCs comprise only a small
percentage of the entire adventitia cell population, they may also
contribute.
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OBJECTIVES Endothelial progenitor cells (EPCs) play important roles
in the process of reendothelialization and prevent neointimal forma-
tion after vascular injury. Sphingosine-1-phosphate (S1P) can via
the sphingosine-1-phosphate receptor 3 (S1PR3) induce pro-
liferation,migration and angiogenesis of EPCs. This study aims to
investigate effects of transplantation of EPCs overexpressing S1PR3 on
reendothelialization and neointimal formation in response to vascular
injury in mice.
METHODS Spleen-derived EPCs were cultured and expanded in
endothelial basal medium. EPCs were infected with lentivirus vectors
expressing mice S1PR3 (S1PR3- EPCs)or green ﬂuorescent protein(GFP-
EPCs). Three days after gene transfection, the mRNA level and protein
level of S1PR3 were assayed. Mice were administered 200 mL saline
alone or 200 mL saline containing ﬂuorescently labeled EPCs (1  106)
or ﬂuorescently labeled EPCs with expressing S1PR3 (1  106) via tail
vein injection directly after wire-mediated carotid artery injury and
again after 24 h. 14 days after transplantation, cell tracking showed
that transfused EPCs could homeing to the sites of endothelial injury.
RESULTS At day 7, the reendothelialized area in the S1PR3- EPCs
transplanted arteries (56.32  6.33%) was signiﬁcantly larger than that
in the GFP- EPCs transplanted arteries (42.474.69%; p<0.05) and that
in the saline control group (28.31  7.32%, p<0.01). At day 14, the
reendothelialized area in the S1PR3- EPCs transplanted arteries (72.28
8.37%) was signiﬁcantly larger than that in the GFP- EPCs transplanted
arteries (50.21  5.66%, p<0,01) and that in the saline control group
(29.98  7.58%, p<0.01). At day 14, a signiﬁcant decrease (P < 0.05) in
neointimal /media (NI/M )ratiowas noted in the S1PR3- EPCs group (0.31
 0.02) as compared with that in the GFP- EPCs group (0.45 0.10) and
in the saline control group (0.770.21). Our results showed that EPCs
overexpressing S1PR3 signiﬁcantly accelerates reendothelialization
and mitigates neointimal formation in the early phase after carotid ar-
tery injury in mice.
CONCLUSIONS Our data suggest that transplantation of EPCs over-
expressing S1PR3 can have a combined effect of both amplifying the
reendothelialization capacity of EPCs and inhibiting neointima for-
mation so as to facilitate better inhibition of adverse remodeling after
vascular injury. Therefore, gene modiﬁed EPCs may be applied in
clinical progenitor cell therapy to improve vascular repair after
vascular injury.
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OBJECTIVES The aim of this study was to determine the expression
proﬁle of circular RNAs (circRNAs) in oxidized low-density lipoprotein(ox-LDL) treated human umbilical vein endothelial cells (HUVECs)
compared with normal HUVECs through human circRNA microarray
and predict their miRNA binding sites.
METHODS The global circRNAs expression proﬁles in ox-LDL treated
HUVECs compared with normal HUVECs were measured by the
Arraystar Human circRNA Array (8x15K, Arraystar). Agilent Feature
Extraction software (version 11.0.1.1) was used to analyze acquired
array images. The circRNA/microRNA interaction was predicted with
Arraystar’s home-made miRNA target prediction software.
RESULTS Compared with normal HUVECs, 24 circRNAs were different
expression (fold change1.5, p-value cut-off is 0.05) in ox-LDL treated
HUVECs. 15 circRNA were up-regulated and 9 circRNAs were down-
regulated. The most up-regulated circRNA was circRNA-104137 and
the most down-regulated circRNA was circRNA-100188. The miRNA
binding sites of circRNA-104137 were miR-455-3p, miR-218-1-3p, miR-
423-5p, miR-503-5p and miR-223-3p. The miRNA binding sites of
circRNA-100188 were miR-637, miR-608, miR-328-5p, miR-877-3p and
miR-185-3p.
CONCLUSIONS The aberrantly expression proﬁle of circRNAs in ox-
LDL treated HUVECs compared with normal HUVECs indicates the
potential roles of circRNAs in endothelial dysfunction. This study may
provide new insights into the mechanism and potential targets for the
endothelial dysfunction.GW26-e1596
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OBJECTIVES Adropin is a newly-identiﬁed secretary protein that
participates in the regulation of energy homeostasis and insulin
response. Growing published evidence presented the beneﬁcial as-
sociation of adropin with coronary artery disease. A laboratory test
showed the beneﬁcial effects of adropin on endothelial cells prolif-
eration and migration. The endothelial cell dysfunction and prolifer-
ation of vascular smooth muscle cell form the core mechanism of
atherosclerosis. Therefore, to increase the expression of adropin by
some therapy may play a role in the prevention and treatment of
atherosclerosis. In the present study, the effects of atorvastatin on
mRNA and protein expression of adropin in cultured human umbilical
vein endothelial cells (HUVEC) and rat artery smooth muscle cell
(RASMC) were investigated.
METHODS HUVEC and RASMC were cultured in vitro with atorvas-
tatin of 0.002, 0.02, 0.2, 2 and 20 umol/L for 6, 12 and 24 hours (h).
The proliferation of HUVEC and RASMC were detected by MTT chro-
matometry. RT-PCR, and ELISA were performed to present the
expression of adropin mRNA and adropin protein respectively.
RESULTS The proliferation of HUVEC was promoted after co-incu-
bation with atorvastain from 0.002 to 20 umol/L concentration, and
the peak was at 20umol/L (versus control, P<0.05) and 24 h (versus
6 h, P<0.05). Atorvastatin upregulated the expression of adropin
mRNA and adropin protein dose-dependently and time-dependently
in HUVEC with a peak at 20umol/L (versus control, P<0.01) and 24
h (versus 6 h, P<0.01). Adropin protein concentration in culture
medium was positively correlated with the OD value indicating
proliferation at 12 h (P¼0.001) and 24 h (P<0.001) after co-
incubation.
The proliferation of RASMC was decreased after co-incubation with
atorvastain from 0.002 to 20umol/L concentration, and the valley
was at 20umol/L (versus control, P<0.05) and 24 h (versus 6 h,
P<0.05). Atorvastatin upregulated the expression of adropin mRNA
and adropin protein in RASMC with a peak at 0.02 umol/L (versus
control and 20 umol/L, P<0.05) and 24 h (versus 6 h, P<0.01).
Adropin protein concentration in culture medium was positively
correlated with the OD value at 12 h (P¼0.002) and 24 h (P¼0.001)
after co-incubation.
CONCLUSIONS Atorvastatin promoted the expression of adropin in
HUVEC and RASMC at a appropriate range of concentration, with the
corresponding results that proliferation of HUVEC was promoted but
RASMC proliferation was inhibited in the test concentration range of
atorvastatin.
